Staar Surgical price target raised to $20 from $17 at Canaccord

Canaccord raised the firm’s price target on Staar Surgical (STAA) to $20 from $17 and keeps a Hold rating on the shares. The firm said they delivered an expectedly tough Q1 in terms of its results, but the tone of the earnings call was more upbeat than expected especially given that guidance was withdrawn, and as a result, the firm is taking its estimates up.